Wall Street is positive on Microbot Medical Inc (MBOT). On average, analysts give MBOT a Strong Buy rating. The average price target is $20, which means analysts expect the stock to rise by 231.67% over the next twelve months. That average ranking earns MBOT an Analyst Rating of 74, which is better than 74% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating MBOT a Strong Buy today. Find out what this means to you and get the rest of the rankings on MBOT!